Drug profile · INN
desmopressin acetate
MINIRIN
desmopressin acetate (MINIRIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
Drug details — desmopressin acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 8
- Programs
- 8
- Data quality
- 0.89
Quick answer
desmopressin acetate (MINIRIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vasopressin receptor agonist
Primary target: Vasopressin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
-
US 12390509
Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof
granted -
US 12351611
Molecules for organelle-specific protein delivery
granted -
US 12091437
Molecules for organelle-specific protein delivery
granted -
US 11976100
Methods for treating myelin associated diseases and mitochondria associated diseases
granted -
US 11891420
Molecules for organelle-specific protein delivery
granted -
CA 2723411
PROCEDE
granted -
TW 200942531
Crystal forms of a nitrocatechol
granted -
WO 2009084970
3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
granted
Frequently asked questions
What is desmopressin acetate?
desmopressin acetate (MINIRIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desmopressin acetate?
MINIRIN is a marketed brand name for desmopressin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desmopressin acetate?
desmopressin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.